The Pediatric Multidisciplinary Research Unit conducts research on neurodevelopmental and congenital conditions.
For more information on any of our research studies please call (520) 626 - 1994 or email@example.com.
The Study of a Biologic Medication in Autism (blüm)
Participate or help us spread the word. The Pediatric Multidisciplinary Research Unit has partnered with Curemark for the blüm Study (The Study of a Biologic Medication in Autism) to determine whether its investigational drug, CM-AT, is safe and effective in treating the symptoms of Autism in children ages 3-8. The 14-week randomized, double-blind Phase III study includes behavioral assessments and monitoring – no blood draws! For more information visit: http://1.usa.gov/1MHDQxB
Congenital Heart Surveillance To Recognize Outcomes, Needs, and well-beinG (CHSTRONG)
Arizona is part of a national study to conduct population-based surveillance through survey for individuals who were born with congenital heart defects and are 18 - 31 years of age. If you were born in Arizona and would like to participate in this study please contact us.
Autism and Developmental Disabilities Monitoring Network (ADDM)
The Autism and Developmental Disabilities Monitoring Network is a group of programs funded by CDC to estimate the number of children with autism spectrum disorder (ASD) and other developmental disabilities living in different areas of the United States. Arizona has been a member of this program for over 12 years. For more information visit http://www.cdc.gov/ncbddd/autism/addm.html. Click here to download the most recent report about autism in Arizona.
Ongoing data projects
We have numerous other data projects related to autism, autoimmune encephalopathy, congenital heart defects and neurodevelopment. Please contact us if you would like to know more (520)626-1994.